HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thoracic epidural analgesia compared with patient controlled intravenous morphine after upper abdominal surgery.

Abstract
Twenty-one ASA I or II patients undergoing upper abdominal surgery were studied for 24 hours after operation. They were entered into a prospective, randomised study of patient-controlled intravenous morphine compared with continuous thoracic epidural fentanyl combined with 0.2% bupivacaine. Pain relief was superior in the bupivacaine series (P < 0.05) throughout the 24 hour study period and this was associated with significantly greater pulmonary ventilation compared with the PCA series. Forced expiratory parameters were reduced in both series after the operation but significantly less so in the epidural group. There was a reduced incidence of emetic symptoms in the epidural group (P < 0.05) but the incidence of other minor side effects did not differ significantly. Thoracic epidural fentanyl/bupivacaine results in significantly better analgesia than patient-controlled intravenous morphine.
AuthorsK A George, P M Wright, A M Chisakuta, N V Rao
JournalActa anaesthesiologica Scandinavica (Acta Anaesthesiol Scand) Vol. 38 Issue 8 Pg. 808-12 (Nov 1994) ISSN: 0001-5172 [Print] England
PMID7887102 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Morphine
  • Fentanyl
  • Bupivacaine
Topics
  • Abdomen (surgery)
  • Adult
  • Aged
  • Analgesia, Epidural (adverse effects)
  • Analgesia, Patient-Controlled (adverse effects)
  • Bupivacaine (adverse effects)
  • Female
  • Fentanyl (adverse effects)
  • Hemodynamics (drug effects)
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Morphine (administration & dosage, adverse effects)
  • Pain Measurement
  • Pain, Postoperative (drug therapy)
  • Prospective Studies
  • Respiratory Mechanics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: